BUDGET clothing store Primark has announced plans to open another branch in Madrid next month – the chain's 61st retail outlet in Spain.
No scientific evidence for therapeutic cannabis says OMC
02/12/2017
The Collegiate Medical Organization (OMC) has considered today that "in the light of current scientific knowledge", for the time being, no evidence exists for the therapeutic use of cannabis to be assessed.
The General Assembly has unanimously endorsed a report requesting that the therapeutic use of cannabis have a solid scientific backing, be subject to strict control of the Spanish Agency for Medicines and Health Products (AEMPS) and follow the procedures normally established for any other drug.
The WTO says so after the Health and Social Services Commission of Congress this week gave the green light to the creation of a subcommittee to analyze the possible regulation in Spain of the therapeutic use of this drug and its derivatives, fruit of a proposal by Ciudadanos Law (Cs).
Doctors warn that the use of cannabis is subject to the possibility of adverse effects to the central nervous system that can cause psychic alterations, in addition to its repercussions on the respiratory system.
According to the WTO, the World Medical Association itself has recognised and described "serious harmful effects" to health caused by this substance: psychiatric comorbidities, demotivation, polydrug use, even as a trigger for traffic accidents.
Other recent studies, says the report, has shown that the composition of marijuana smoke is similar to that of tobacco smoke, "which should alert for its possible effect on lung health."
Cs initiative shows that cannabis has shown important effects in the prevention of nausea and vomiting of chemotherapy, in the improvement of neuropathic pain and spasticity characteristic of multiple sclerosis and as a remedy to combat seizures in epilepsy.
The medical organization points out that there are other medicines to prevent nausea and vomiting in cancer patients undergoing chemotherapy, and that no international guide recommends cannabis derivatives for neuropathic pain, nor is there any scientific evidence in the case of the treatment of epilepsies.
Related Topics
The Collegiate Medical Organization (OMC) has considered today that "in the light of current scientific knowledge", for the time being, no evidence exists for the therapeutic use of cannabis to be assessed.
The General Assembly has unanimously endorsed a report requesting that the therapeutic use of cannabis have a solid scientific backing, be subject to strict control of the Spanish Agency for Medicines and Health Products (AEMPS) and follow the procedures normally established for any other drug.
The WTO says so after the Health and Social Services Commission of Congress this week gave the green light to the creation of a subcommittee to analyze the possible regulation in Spain of the therapeutic use of this drug and its derivatives, fruit of a proposal by Ciudadanos Law (Cs).
Doctors warn that the use of cannabis is subject to the possibility of adverse effects to the central nervous system that can cause psychic alterations, in addition to its repercussions on the respiratory system.
According to the WTO, the World Medical Association itself has recognised and described "serious harmful effects" to health caused by this substance: psychiatric comorbidities, demotivation, polydrug use, even as a trigger for traffic accidents.
Other recent studies, says the report, has shown that the composition of marijuana smoke is similar to that of tobacco smoke, "which should alert for its possible effect on lung health."
Cs initiative shows that cannabis has shown important effects in the prevention of nausea and vomiting of chemotherapy, in the improvement of neuropathic pain and spasticity characteristic of multiple sclerosis and as a remedy to combat seizures in epilepsy.
The medical organization points out that there are other medicines to prevent nausea and vomiting in cancer patients undergoing chemotherapy, and that no international guide recommends cannabis derivatives for neuropathic pain, nor is there any scientific evidence in the case of the treatment of epilepsies.
Related Topics
More News & Information
The Council of Ministers has approved the preliminary draft of a new law on social services, leaving overall power, as it is now, in the hands of the autonomous communities, but establishing a common framework of...
Sevilla's Plaza de España, built in 1928, and its Parque de María Luisa, two of the city's most popular places with tourists, will soon be 'smoke-free' zones.
TOP-END high-street fashion chain Adolfo Domínguez is expanding its empire outside of its home country after reporting a rise in sales abroad of nearly 30% in spring.